OverviewSuggest Edit

Alteogen is a biopharmaceutical company that develops therapeutic proteins, antibody-drug conjugates, (ADCs), and monoclonal antibody biosimilars. It provides NexP fusion technology that supports the production of Human Growth Hormone (HGH), long-acting exenatide (for diabetes), and long-acting Factor VIIa (for hemophilia).
TypePublic
Founded2008
Websitealteogen.com

Latest Updates

Share Price (Sept 2021)₩86.2 K(+7%)
Cybersecurity ratingBMore

Alteogen Financials and Metrics

Alteogen Revenue

Market capitalization (3-Sept-2021)

1.2t

Closing stock price (3-Sept-2021)

86.2k
Alteogen's current market capitalization is ₩1.2 t.
Show all financial metrics

Alteogen Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Alteogen Online and Social Media Presence

Embed Graph

Alteogen Frequently Asked Questions

  • When was Alteogen founded?

    Alteogen was founded in 2008.

  • Who are Alteogen competitors?

    Competitors of Alteogen include Abarceo Pharma, glyscend and Amarillo Biosciences.